Periodontal disease and its impact on general health in Latin America. Section V: Treatment of periodontitis.
Ricardo Guimarães FischerRonaldo Lira-JuniorBelen Retamal-ValdesLuciene Cristina de FigueiredoZilson MalheirosBernal StewartMagda Gomes FeresPublished in: Brazilian oral research (2020)
Gingivitis and periodontitis are associated with a negative impact on Oral Health Related Quality of Life (OHRQoL), exerting a significant influence on aspects related to the patients' function and esthetics. Periodontitis has been associated with several systemic conditions, including adverse pregnancy outcomes, cardiovascular diseases, type 2 diabetes mellitus (DM), respiratory disorders, fatal pneumonia in hemodialysis patients, chronic renal disease and metabolic syndrome. The aim of this paper was to review the results of different periodontal treatments and their impacts on patients' OHRQoL and systemic health. Non-surgical and surgical periodontal treatments are predictable procedures in terms of controlling infection, reducing probing pocket depth and gaining clinical attachment. In addition, the treatment of periodontitis may significantly improve OHRQoL and promote a reduction in the levels of systemic markers of inflammation, including some cytokines associated with cardiovascular diseases. Studies have also suggested that periodontal treatment may improve glycemic control in patients with DM. Strategies and actions for preventing the onset and recurrence of periodontitis, and the challenges facing the field of periodontology in the XXI century are presented in this review.
Keyphrases
- glycemic control
- end stage renal disease
- metabolic syndrome
- cardiovascular disease
- ejection fraction
- newly diagnosed
- type diabetes
- public health
- chronic kidney disease
- peritoneal dialysis
- mental health
- prognostic factors
- coronary artery disease
- blood glucose
- climate change
- social media
- health information
- adipose tissue
- molecular dynamics simulations
- skeletal muscle
- cardiovascular events
- adverse drug